Predictors of Hemorrhage Following Intra-Arterial Thrombolysis for Acute Ischemic Stroke: The Role of Pial Collateral Formation

被引:107
作者
Christoforidis, G. A. [1 ]
Karakasis, C.
Mohammad, Y. [3 ]
Caragine, L. P. [2 ]
Yang, M.
Slivka, A. P. [3 ]
机构
[1] Ohio State Univ, Med Ctr, Coll Med, Dept Radiol, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Neurosurg, Coll Med, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Neurol, Coll Med, Columbus, OH 43210 USA
关键词
TISSUE-PLASMINOGEN-ACTIVATOR; INTRACEREBRAL HEMORRHAGE; INTRACRANIAL HEMORRHAGE; PROACT II; TRANSFORMATION; THERAPY; RECANALIZATION; HYPERGLYCEMIA; RISK;
D O I
10.3174/ajnr.A1276
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND AND PURPOSE: The extent of pial collateral formation during acute ischemic stroke has been shown to influence outcomes. This study examines whether angiographic assessment of pial collateral formation is predictive of hemorrhagic transformation following intra-arterial thrombolysis (IAT) for acute ischemic stroke. MATERIALS AND METHODS: Rates of any hemorrhage and significant hemorrhage >25 mL) were reviewed in 104 consecutive patients who underwent IAT following acute ischemic stroke. The influence of the anatomic extent of pial collateral formation on the rates of hemorrhage and significant hemorrhage relative to known predictors for hemorrhagic transformation (presenting systolic blood pressure, blood glucose level, platelet level, and National Institutes of Health Stroke Scale [NIHSS] score, history of diabetes, time to treatment, age, sex, occlusion site, and extent of reperfusion) was analyzed by using logistic regression models. RESULTS: Rates of any hemorrhage and significant hemorrhage were 25.2% (26/104) and 9.7% (10/104), respectively. The rate of significant hemorrhage was 25.0% (8/32) in patients with poor pial collaterals and 2.78% (2/72) in those with good pial collaterals (P = .0004, Pearson correlation). The rate of any hemorrhage was also significantly higher in patients with poor pial collaterals (40.6% versus 18.1%; P = .0142, Pearson correlation), Logistic regression analyses revealed that pial collateral formation (odds ratio [OR] = 3.04), history of diabetes (OR = 4.83), platelets <200,000/mu L (OR = 2.95), and time to treatment <3 hours (OR = 12.0) were statistically significant predictors of hemorrhage, whereas pial collateral formation (OR = 13 1) and platelets <200,000/mu L (OR = 8.1) were statistically significant predictors of significant hemorrhage. CONCLUSIONS: Poor pial collateral formation is associated with higher incidence and larger size of hemorrhage following IAT.
引用
收藏
页码:165 / 170
页数:6
相关论文
共 29 条
[1]   Recanalisation of middle cerebral artery occlusion after intra-arterial thrombolysis: different recanalisation grading systems and clinical functional outcome [J].
Arnold, M ;
Nedeltchev, K ;
Remonda, L ;
Fischer, U ;
Brekenfeld, C ;
Keserue, B ;
Schroth, G ;
Mattle, HP .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (10) :1373-1376
[2]   Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke [J].
Brott, T ;
Broderick, J ;
Kothari, R ;
ODonoghue, M ;
Barsan, W ;
Tomsick, T ;
Spilker, J ;
Miller, R ;
Sauerbeck, L ;
Farrell, J ;
Kelly, J ;
Perkins, T ;
Miller, R ;
McDonald, T ;
Rorick, M ;
Hickey, C ;
Armitage, J ;
Perry, C ;
Thalinger, K ;
Rhude, R ;
Schill, J ;
Becker, PS ;
Heath, RS ;
Adams, D ;
Reed, R ;
Klei, M ;
Hughes, A ;
Anthony, J ;
Baudendistel, D ;
Zadicoff, C ;
Rymer, M ;
Bettinger, I ;
Laubinger, P ;
Schmerler, M ;
Meiros, G ;
Lyden, P ;
Dunford, J ;
Zivin, J ;
Rapp, K ;
Babcock, T ;
Daum, P ;
Persona, D ;
Brody, M ;
Jackson, C ;
Lewis, S ;
Liss, J ;
Mahdavi, Z ;
Rothrock, J ;
Tom, T ;
Zweifler, R .
STROKE, 1997, 28 (11) :2109-2118
[3]   Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke [J].
Castellanos, M ;
Leira, R ;
Serena, J ;
Pumar, JM ;
Lizasoain, I ;
Castillo, J ;
Dávalos, A .
STROKE, 2003, 34 (01) :40-45
[4]  
Christoforidis GA, 2005, AM J NEURORADIOL, V26, P1789
[5]   Size matters - Hemorrhage volume as an objective measure to define significant intracranial hemorrhage associated with thrombolysis [J].
Christoforidis, Gregory A. ;
Slivka, Andrew ;
Mohammad, Yousef ;
Karakasis, Christopher ;
Avutu, Bindu ;
Yang, Ming .
STROKE, 2007, 38 (06) :1799-1804
[6]   Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset - The ATLANTIS study: A randomized controlled trial [J].
Clark, WM ;
Wissman, S ;
Albers, GW ;
Jhamandas, JH ;
Madden, KP ;
Hamilton, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2019-2026
[7]   RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE THROMBOTIC AND EMBOLIC STROKE [J].
DELZOPPO, GJ ;
POECK, K ;
PESSIN, MS ;
WOLPERT, SM ;
FURLAN, AJ ;
FERBERT, A ;
ALBERTS, MJ ;
ZIVIN, JA ;
WECHSLER, L ;
BUSSE, O ;
GREENLEE, R ;
BRASS, L ;
MOHR, JP ;
FELDMANN, E ;
HACKE, W ;
KASE, CS ;
BILLER, J ;
GRESS, D ;
OTIS, SM .
ANNALS OF NEUROLOGY, 1992, 32 (01) :78-86
[8]   Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke [J].
Demchuk, AM ;
Morgenstern, LB ;
Krieger, DW ;
Chi, TL ;
Hu, W ;
Wein, TH ;
Hardy, RJ ;
Grotta, JC ;
Buchan, AM .
STROKE, 1999, 30 (01) :34-39
[9]   MODERATE HYPERGLYCEMIA WORSENS ACUTE BLOOD-BRAIN-BARRIER INJURY AFTER FOREBRAIN ISCHEMIA IN RATS [J].
DIETRICH, WD ;
ALONSO, O ;
BUSTO, R .
STROKE, 1993, 24 (01) :111-116
[10]   Intra-arterial prourokinase for acute ischemic stroke - The PROACT II study: A randomized controlled trial [J].
Furlan, A ;
Higashida, R ;
Wechsler, L ;
Gent, M ;
Rowley, H ;
Kase, C ;
Pessin, M ;
Ahuja, A ;
Callahan, F ;
Clark, WM ;
Silver, F ;
Rivera, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2003-2011